{"organizations": [], "uuid": "f765ca3531d87ce5f0e8bad274bf62f4c2a6ba61", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-intercept-pharmaceuticals-says-cos/brief-intercept-pharmaceuticals-says-cos-board-increased-size-of-board-from-nine-directors-to-ten-directors-idUSFWN1S41C6", "country": "US", "domain_rank": 408, "title": "BRIEF-Intercept Pharmaceuticals Says Co's Board Increased Size Of Board From Nine Directors To Ten Directors", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-27T15:37:00.000+03:00", "replies_count": 0, "uuid": "f765ca3531d87ce5f0e8bad274bf62f4c2a6ba61"}, "author": "", "url": "https://www.reuters.com/article/brief-intercept-pharmaceuticals-says-cos/brief-intercept-pharmaceuticals-says-cos-board-increased-size-of-board-from-nine-directors-to-ten-directors-idUSFWN1S41C6", "ord_in_thread": 0, "title": "BRIEF-Intercept Pharmaceuticals Says Co's Board Increased Size Of Board From Nine Directors To Ten Directors", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-intercept pharmaceuticals says co", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "co's board", "sentiment": "none"}, {"name": "intercept pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27 (Reuters) - Intercept Pharmaceuticals Inc:\n* INTERCEPT PHARMACEUTICALS SAYS EFFECTIVE APRIL 24, CO'S BOARD INCREASED SIZE OF BOARD FROM NINE DIRECTORS TO TEN DIRECTORS - SEC FILING Source text: [ bit.ly/2JsU4uo ] Further company coverage:\n ", "external_links": ["https://bit.ly/2JsU4uo"], "published": "2018-04-27T15:37:00.000+03:00", "crawled": "2018-04-27T16:02:21.007+03:00", "highlightTitle": ""}